Dr. Aggarwal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
505 Parnassus Ave
Room M987
San Francisco, CA 94143Phone+1 415-476-1000- Is this information wrong?
Education & Training
- University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2010 - 2013
- University of California (San Francisco)Residency, Internal Medicine, 2006 - 2009
- Northwestern University The Feinberg School of MedicineClass of 2006
Certifications & Licensure
- CA State Medical License 2008 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer Start of enrollment: 2012 Jun 01
- Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer Start of enrollment: 2013 Oct 29
- Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer Start of enrollment: 2013 Jul 08
- Join now to see all
Publications & Presentations
PubMed
- Immune Modulation with RANKL Blockade through Denosumab Treatment in Patients with Cancer.Hewitt Chang, Jaqueline Marquez, Brandon K Chen, Daniel M Kim, Michael L Cheng, Eric V Liu, Hai Yang, Li Zhang, Meenal Sinha, Alexander Cheung, Serena S Kwek, Eric D C...> ;Cancer Immunology Research. 2024 Apr 2
- A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC).Wise, D., Pachynski, R., Denmeade, S., Aggarwal, R., Deng, J., Febles, V., Balar, A., Economides, M., Loomis, C., Selvaraj, S., Haas, M., Kagey, M., Newman, W., Baum, ...> ;Prostate Cancer and Prostatic Diseases. 2024 Feb 10
- Biomarkers and novel PET imaging to detect neuroendocrine prostate cancer.Aggarwal, R.> ;Clinical Advances in Hematology & Oncology. 2024 Jan 31
- Join now to see all
Lectures
- Exceptional responders to abexinostat (ABX) plus pazopanib (PAZ) in pretreated renal cell carcinoma (RCC) and other solid tumors: Long-term follow-up of a phase 1b study.2019 ASCO Annual Meeting - 6/1/2019
- DNA repair mutations and treatment-emergent small cell neuroendocrine prostate cancer (t-SCNC) as hallmarks of distinct subgroups of metastatic castration resistant pr...2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Press Mentions
- Breaking the Boundaries Between Radiology and Oncology: GU Oncology Profiles Thomas a. Hope, MDApril 28th, 2022
- Androgen Deprivation Therapy and SARS-CoV-2 in Men with Prostate Cancer: Findings from the University of California Health System RegistryFebruary 8th, 2021
- Xynomic Pharma to Present Long-Term Follow up Data Showing Abexinostat, Combined with Pazopanib, Has Durable Responses in Patients with Pre-Treated Kidney CancerMay 21st, 2019
- Join now to see all
Hospital Affiliations
- UCSF Medical CenterSan Francisco, California
- Zuckerberg San Francisco General Hospital and Trauma CenterSan Francisco, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: